
Sign up to save your podcasts
Or
Dr. Anna Wolska engages in a discussion with renowned experts, Dr. Catharina Lindholm and Dr. David Jayne, to explore findings from the phase II TULIP Lupus Nephritis trial. This in-depth conversation centers on results from a clinical trial where they evaluated the efficacy of intensified anifrolumab treatment in individuals with active lupus nephritis.
Read the article: http://dx.doi.org/10.1136/lupus-2023-000910
3.9
1414 ratings
Dr. Anna Wolska engages in a discussion with renowned experts, Dr. Catharina Lindholm and Dr. David Jayne, to explore findings from the phase II TULIP Lupus Nephritis trial. This in-depth conversation centers on results from a clinical trial where they evaluated the efficacy of intensified anifrolumab treatment in individuals with active lupus nephritis.
Read the article: http://dx.doi.org/10.1136/lupus-2023-000910
11,115 Listeners
39 Listeners
4 Listeners
55 Listeners
7 Listeners
4 Listeners
3 Listeners
1 Listeners
4 Listeners
9 Listeners
41 Listeners
14 Listeners
1 Listeners
46 Listeners
0 Listeners
6 Listeners
493 Listeners
277 Listeners
3,323 Listeners
3 Listeners
87 Listeners
27 Listeners
1,084 Listeners
1,674 Listeners
23 Listeners
350 Listeners
23 Listeners
30 Listeners
364 Listeners
42 Listeners
2 Listeners
0 Listeners
0 Listeners
0 Listeners